The role of premorbid transthoracic echocardiogram in identifying adverse clinical outcomes in patients admitted with COVID-19

27 August 2021 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Christopher Lee

University of California, Los Angeles, Los Angeles (United States of America)

124 More presentations in this session

Presentation thumbnail

Left atrial volume changes during exercise stress echocardiography in heart failure and hypertrophic cardiomyopathy

Doctor C. Prota (Salerno, IT)

Abstract Slides

Presentation thumbnail

The efficacy of three dimensional echocardiography in assessment of aortic atherosclerotic plaques compared to two dimensional echocardiography

Doctor M. Behjati (Isfahan, IR)

Abstract Slides

Presentation thumbnail

Global longitudinal strain as a predictor of cardiovascular events and mortality in patients with ischemic heart disease and heart failure with preserved/mid-range ejection fraction

Mr J. Santos (Viseu, PT)

Abstract Slides

Presentation thumbnail

Myocardial injury in stress echocardiography: comparison of dobutamine, dipyridamole and dynamic stress echocardiography - single centre study

Professor R. Pudil (Prague, CZ)

Abstract Slides

Presentation thumbnail

Severe aortic stenosis echocardiographic thresholds revisited

Doctor S. Schwartzenberg (Petah Tikva, IL)

Abstract Slides

Access the full session

Session thumbnail

Echocardiography ePosters

The Event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

You may be interested in

Congress Presentation

Diastolic function and left atrial pressures

Congress Presentation

LV diastolic function: how to deal with challenges

Congress Presentation

Evaluation of diastolic function and LV filling pressures: limitations of current guidelines 

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources